Journal article

A mindfulness-based, cognitive, social, digital relapse-prevention intervention for youth with depression in Australia: study protocol for a randomised controlled trial of Rebound

SN Mangelsdorf, D Cagliarini, YY Lee, C Mihalopoulos, V Liu, L Valentine, S Bendall, P Koval, S D'alfonso, C Davey, P Russon, J Phillips, C Gonzalez-Blanch, B Pawsey, RM Ryan, A Parker, S Hetrick, S Rice, R Lederman, H Herrman Show all

BMJ Open | Published : 2024

Abstract

Introduction Major depressive disorder (MDD) causes significant disease burden and functional impairment during adolescence and young adulthood. While most young people recover from their first episode, around two-thirds will experience one or more relapses, which can become more severe and treatment-resistant with each episode. To address relapse in MDD, we developed a moderated online social therapy platform (titled Rebound) that integrates: (i) peer-to-peer social networking; (ii) tailored third-wave therapeutic content targeting mindfulness, self-compassion and rumination; and (iii) three types of human support (clinicians, peer workers, career consultants), informed by self-determinatio..

View full abstract

Grants

Awarded by University of Melbourne


Funding Acknowledgements

The Rebound trial was supported by a grant from the National Health and Medical Research Council (NHMRC ID# 2018/GNT1144563) from the Australian Government. MA- J was supported by an Investigator Grant (APP1177235) from the National Health and Medical Research Council and a Dame Kate Campbell Fellowship from The University of Melbourne.